These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15814626

  • 1. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y, McDermott MP, Ahrendt SA.
    Clin Cancer Res; 2005 Apr 01; 11(7):2502-9. PubMed ID: 15814626
    [Abstract] [Full Text] [Related]

  • 2. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.
    Lung Cancer; 2006 Apr 01; 52(1):9-14. PubMed ID: 16499995
    [Abstract] [Full Text] [Related]

  • 3. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem MF, Keohavong P.
    Carcinogenesis; 2003 Oct 01; 24(10):1671-6. PubMed ID: 12844488
    [Abstract] [Full Text] [Related]

  • 4. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking-related non-small cell lung cancer patients.
    Murata M, Tagawa M, Kimura H, Kakisawa K, Shirasawa H, Fujisawa T.
    Int J Oncol; 1998 Mar 01; 12(3):577-81. PubMed ID: 9472095
    [Abstract] [Full Text] [Related]

  • 5. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H, Ekstrøm PO, Ryberg D, Skaug V, Andreassen T, Stangeland L, Haugen A, Zienolddiny S.
    Cancer Epidemiol Biomarkers Prev; 2007 Oct 01; 16(10):2077-81. PubMed ID: 17932356
    [Abstract] [Full Text] [Related]

  • 6. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J, Gene M, Gomez-Catalan J, Galan C, Firvida J, Fuentes M, Rodamilans M, Huguet E, Estape J, Corbella J.
    Cancer Epidemiol Biomarkers Prev; 1996 May 01; 5(5):337-42. PubMed ID: 9162298
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
    Boldrini L, Gisfredi S, Ursino S, Lucchi M, Greco G, Mussi A, Fontanini G.
    Oncol Rep; 2008 Mar 01; 19(3):771-3. PubMed ID: 18288414
    [Abstract] [Full Text] [Related]

  • 8. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP, Wong RH, Wu TC, Cheng YW, Chen CY, Lee H.
    Ann Surg Oncol; 2009 Jul 01; 16(7):1918-24. PubMed ID: 19434453
    [Abstract] [Full Text] [Related]

  • 9. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
    Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, Lynch TJ, Wain JC, Su L, Christiani DC.
    Cancer Res; 2001 Dec 15; 61(24):8718-22. PubMed ID: 11751390
    [Abstract] [Full Text] [Related]

  • 10. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT.
    Carcinogenesis; 2005 Oct 15; 26(10):1770-3. PubMed ID: 15905205
    [Abstract] [Full Text] [Related]

  • 11. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2000 Oct 15; 9(10):1037-42. PubMed ID: 11045785
    [Abstract] [Full Text] [Related]

  • 12. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM, Shun CT, Wu MT, Chen YY, Yang SY, Hung HI, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC.
    Mutat Res; 2006 Feb 22; 594(1-2):181-8. PubMed ID: 16318864
    [Abstract] [Full Text] [Related]

  • 13. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P, Sengupta S.
    Gynecol Oncol; 2005 Oct 22; 99(1):176-82. PubMed ID: 16054204
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
    Malisic E, Jankovic R, Slavkovic D, Milovic-Kovacevic M, Radulovic S.
    J BUON; 2010 Oct 22; 15(1):101-6. PubMed ID: 20414935
    [Abstract] [Full Text] [Related]

  • 17. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.
    Cancer Lett; 2004 Jul 16; 210(2):197-203. PubMed ID: 15183535
    [Abstract] [Full Text] [Related]

  • 18. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
    Furihata M, Takeuchi T, Matsumoto M, Kurabayashi A, Ohtsuki Y, Terao N, Kuwahara M, Shuin T.
    Clin Cancer Res; 2002 May 16; 8(5):1192-5. PubMed ID: 12006537
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
    Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H.
    Oncogene; 1990 Oct 16; 5(10):1603-10. PubMed ID: 1979160
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.